| Members |
targetComponentId |
| hæmangiom |
Benign haemangioma |
| Hemangiopericytic meningioma |
Solitary fibrous tumor |
| hæmangiopericytom |
Solitary fibrous tumor |
| benignt hæmangiopericytom |
Solitary fibrous tumor and hemangiopericytoma grade 1 (morphologic abnormality) |
| malignt hæmangiopericytom |
Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality) |
| Hæmartrose, ikke nærmere specificeret |
Hemarthrosis |
| Hemarthrosis of other site, NEC |
Hemarthrosis |
| Hæmartrose med anden specificeret lokalisation |
Hemarthrosis |
| Hematocrit - PCV - NOS |
Hematocrit determination |
| bivirkning af hæmatologiske midler |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
| Hematology NOS |
Haematology test |
| Hematology finding |
Hematology report (record artifact) |
| fund vedr. hæmatologi |
Hematology report (record artifact) |
| Abnorme hæmatologifund |
Haematology test outside reference range |
| Hematoside |
GM3-ganglioside |
| Hæmaturi, ikke nærmere specificeret |
Blood in urine |
| Hemoglobin F-Calluna |
Hemoglobin F-Heather |
| Hemoglobin F-Iwata |
Hemoglobin F-Minoo |
| Hemoglobin F-Kuala Lumpur |
Hemoglobin F-Urumqi |
| Hemoglobin F-Siena |
Hemoglobin F-Carlton |
| Hemoglobin F-Yamaguchi |
Hemoglobin F-Marietta |
| Hemoglobin J-Kaohslung |
Haemoglobin J-Kaohsiung |
| Hæmoglobin J-Nayanza |
Haemoglobin J-Nyanza |
| Hemoglobin S |
Hemoglobin S |
| Hemoglobin S disease |
Sickle cell-hemoglobin SS disease |
| Hemoglobin S disease with crisis |
Hemoglobin SS disease with crisis (disorder) |
| Hemoglobin S disease without crisis |
Hemoglobin SS disease without crisis (disorder) |
| Hemoglobin estimation NOS |
Hemoglobin level estimation |
| Hemoglobin variant NOS |
Hemoglobin variant test |
| hæmoglobinværdier meget høje |
Hemoglobin above reference range |
| hæmoglobin meget lavt |
Hemoglobin below reference range (finding) |
| Hemolysis |
Hemolysis |
| Hemolytic disease NOS |
Hemolytic disorder |
| Hemolytic disease due to other isoimmunization, NEC |
Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization |
| Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
| faecesanalyse for hæmoglobin vha. Hemoquant |
Evaluation of stool specimen |
| Hemorrhage NOS |
Bleeding |
| Hemorrhage control by packing NOS |
Packing for haemorrhage |
| blødning forårsaget af en anordning, implantat OG/ELLER graft |
Bleeding |
| Hemorrhagic fever with renal syndrome |
A rare rodent-borne, potentially severe, hemorrhagic disease caused by Old World Hantaviruses characterized by high fever, malaise, headache, myalgia, arthralgia, backache, abdominal pain, oliguria/renal failure and systemic hemorrhagic manifestations. |
| Hæmoragisk nefrose-nefrit |
A rare rodent-borne, potentially severe, hemorrhagic disease caused by Old World Hantaviruses characterized by high fever, malaise, headache, myalgia, arthralgia, backache, abdominal pain, oliguria/renal failure and systemic hemorrhagic manifestations. |
| Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
| Hæmorider, ikke nærmere specificeret |
Hemorrhoids |
| Hæmorider med andre komplikationer, ikke nærmere specificeret |
Hemorrhoids |
| Hæmorider uden komplikation |
Hemorrhoids |
| Hemostasis of unspecified organ |
Control of hemorrhage |
| Hepadnaviridae |
Family Hepadnaviridae (organism) |
| heparin 100 enheder |
Product containing heparin (medicinal product) |
| heparin 10 enheder |
Product containing heparin (medicinal product) |
| Heparin cofactor I |
Antithrombin III |
| heparinnatrium 100 enheder/ml opløsning |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
| heparinnatrium 1000 IE/natriumchlorid 0,9 % infusionsvæske, opløsning, ampul |
Product containing only heparin in parenteral dose form (medicinal product form) |
| heparinnatrium 10 enheder/ml injektionsvæske, opløsning, ampul |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| heparinnatrium 10 enheder/ml opløsning |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
| Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
| Hepatectomy |
Excision of liver (procedure) |
| Hepatic colic |
Biliary colic |
| Hepatitis |
Inflammatory disease of liver |
| Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
| hepatitis B-immunglobulin 1000 IE pulver til injektionsvæske, opløsning, hætteglas |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| hepatitis B-immunglobulin 200 IE pulver til injektionsvæske, opløsning, hætteglas |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| hepatitis B-immunglobulin 500 IE pulver til injektionsvæske, opløsning, hætteglas |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| Hepatitis B screening test |
Hepatitis B screening |
| Hepatitis B screening test |
Hepatitis B screening |
| screeningstest for hepatitis B |
Hepatitis B screening |
| hepatitis B-immunglobulin 217 enheder injektionsvæske, opløsning, hætteglas |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
| hepatitis B-immunglobulin 312 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| hepatitis B-immunglobulin 312 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
| hepatit forårsaget af toksoplasmose |
Hepatitis caused by Toxoplasma gondii |
| Hepatit non-A non-B |
Viral hepatitis |
| Hepatitis panel |
Hepatitis panel measurement |
| Hepatocerebral encephalopathy |
Hepatic encephalopathy |
| Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
| Hereditary disease |
Hereditary disease |
| Hereditary endotheliopathy, retinopathy, nephropathy, stroke syndrome |
An inherited group of small vessel diseases comprised of cerebroretinal vasculopathy (CRV), hereditary vascular retinopathy (HRV) and hereditary endotheliopathy with retinopathy, nephropathy and stroke all exhibiting progressive visual impairment as well as variable cerebral dysfunction. There is evidence the disease is caused by heterozygous mutation in the TREX1 gene on chromosome 3p21. |
| Hereditary malignant neuroendocrine neoplasm of small intestine |
Hereditary well-differentiated neuroendocrine tumor of small intestine (disorder) |
| Hereditær methæmoglobinæmi, enzymatisk type |
A rare red cell disorder classified principally into two clinical phenotypes: autosomal recessive congenital (or hereditary) types I and II (RCM/RHM type 1; RCM/RHM type 2). In RCM type 1, cyanosis from birth is the only symptom. RCM type 2 is much more severe; the cyanosis is accompanied by neurological dysfunction (with intellectual deficit, microcephaly, growth retardation, opisthotonus, strabismus and hypertonia), which usually becomes evident during the first four months of life. RCM type 1 is caused by mutations of the CYB5R3 gene (22q13.31-qter) encoding the NADH-cytochrome b5 reductase (Cb5R) and Cb5R deficiency is limited to the erythrocytes. RCM type 2 is caused by global loss of Cb5R function. RCM type 1 is generally associated with missense mutations, whereas RCM type 2 is more commonly associated with truncating mutations, splicing errors or mutations that lead to disruption of the active site. |
| hereditær nefrogen diabetes insipidus |
Hereditary vasopressin resistance |
| hereditær non-sfærocytisk hæmolytisk anæmi forårsaget af aldolase A-mangel |
Glycogen storage disease due to aldolase A deficiency is an extremely rare glycogen storage disease characterized by hemolytic anemia with or without myopathy or intellectual deficit. Myopathy can be severe enough to result in fatal rhabdomyolysis in some patients. A family with episodic rhabdomyolysis (triggered by fever) without hemolytic anemia has recently been reported. |
| HNSHA forårsaget af NADH-methæmoglobinreductasemangel |
A rare red cell disorder classified principally into two clinical phenotypes: autosomal recessive congenital (or hereditary) types I and II (RCM/RHM type 1; RCM/RHM type 2). In RCM type 1, cyanosis from birth is the only symptom. RCM type 2 is much more severe; the cyanosis is accompanied by neurological dysfunction (with intellectual deficit, microcephaly, growth retardation, opisthotonus, strabismus and hypertonia), which usually becomes evident during the first four months of life. RCM type 1 is caused by mutations of the CYB5R3 gene (22q13.31-qter) encoding the NADH-cytochrome b5 reductase (Cb5R) and Cb5R deficiency is limited to the erythrocytes. RCM type 2 is caused by global loss of Cb5R function. RCM type 1 is generally associated with missense mutations, whereas RCM type 2 is more commonly associated with truncating mutations, splicing errors or mutations that lead to disruption of the active site. |
| Hereditary progressive muscular dystrophy |
Muscular dystrophy |
| Hereditær sensorisk-motorisk neuropati, type V |
A rare axonal hereditary motor and sensory neuropathy with characteristics of slowly progressive distal muscle weakness and atrophy with or without sensory loss resulting in difficulty in walking, foot drop and pes cavus, that may be associated with pyramidal signs (extensor plantar responses, mild increase in tone, brisk tendon reflexes), muscle cramps, pain and spasticity. |
| Hereditary site-specific ovarian cancer syndrome |
A genetic condition characterized by hereditary susceptibility to breast and/or ovarian cancer. It can be defined using family history criteria, or through identification of germline pathogenic variants (GPVs) in clinically validated HBOC genes. However, the genetic basis of about half of clinical HBOC is currently unknown or unexplained by single-gene variants, and approximately half of individuals who harbor PVs in HBOC genes do not have a suggestive family history. |
| hereditær trombocytopeni, ikke klassificeret andetsteds |
Hereditary thrombocytopenic disorder (disorder) |
| Hereditary vascular retinopathy |
An inherited group of small vessel diseases comprised of cerebroretinal vasculopathy (CRV), hereditary vascular retinopathy (HRV) and hereditary endotheliopathy with retinopathy, nephropathy and stroke all exhibiting progressive visual impairment as well as variable cerebral dysfunction. There is evidence the disease is caused by heterozygous mutation in the TREX1 gene on chromosome 3p21. |
| Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
| Hermaphroditism |
Ovotesticular disorder of sex development |
| Hermafroditisme |
Ovotesticular disorder of sex development |
| ikke-farmaceutisk heroin |
Diamorphine (substance) |
| Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
| Herpes simplex - other |
Herpes simplex |
| Herpes simplex - other |
Herpes simplex |
| herpes simplex med komplikationer |
Herpes simplex |
| Herpes simplex with other specified complications |
Herpes simplex |
| Herpes simplex with unspecified complications |
Herpes simplex |
| herpes simplex uden komplikationer |
Herpes simplex |
| herpes zoster med komplikation |
Herpes zoster |
| herpes zoster med komplikation i nervesystemet |
Herpes zoster |
| Herpes zoster med oftalmisk komplikation |
Herpes zoster ophthalmicus |
| Herpes zoster with other central nervous system complication |
Herpes zoster |
| Herpes zoster with other central nervous system complication |
Herpes zoster |
FHIR